section name header

Table 186-4

Drugs Commonly Used for Treatment of Parkinson's Diseasea

AGENTAVAILABLE DOSAGESTYPICAL DOSING

Levodopaa

Carbidopa/levodopa10/100, 25/100, 25/250 mg200-1000 mg levodopa/day
Benserazide/levodopa25/100, 50/200 mg
Carbidopa/levodopa CR25/100, 50/200 mg
Benserazide/levodopa MDS25/200, 25/250 mg
Parcopa10/100, 25/100, 25/250

Rytary (carbidopa/levodopa)

23.75/95, 36.25/145, 48.75/195, 61.25/245

See conversion tables

Carbidopa/levodopa/entacapone

12.5/50/200, 18.75/75/200, 25/100/200, 31.25/125/200, 37.5/150/200, 50/200/200 mg

Dopamine agonists
Pramipexole0.125, 0.25, 0.5, 1.0, 1.5 mg0.25-1.0 mg tid
Pramipexole ER0.375, 0.75, 1.5. 3.0, 4.5 mg1-3 mg/d
Ropinirole0.25, 0.5, 1.0, 3.0 mg6-24 mg/d
Ropinirole XL2, 4, 6, 8 mg6-24 mg/d
Rotigotine patch2-, 4-, 6-, 8-mg patches4-24 mg/d
Apomorphine SC2-8 mg2-8 mg
COMT inhibitors
Entacapone200 mg200 mg with each levodopa dose

Tolcapone

100, 200 mg

100-200 mg tid

Opicapone

50 mg

50 mg HS

MAO-B inhibitors
Selegiline5 mg5 mg bid

Rasagiline

0.5, 1.0 mg

mg QAM

Safinamide

100 mg

100 mg QAM

a Treatment should be individualized. Generally, drugs should be started in low doses and titrated to optimal dose.

Note: Drugs should not be withdrawn abruptly but should be gradually lowered or removed as appropriate.

Abbreviations: COMT, catechol-O-methyltransferase; MAO-B, monoamine oxidase type B; QAM, every morning.